- Press Release Distribution

Extended lymph node removal does not benefit patients with clinically localized muscle-invasive bladder cancer

Results of the definitive SWOG S1011 phase 3 surgical trial, which also found increased toxicities for patients undergoing extended rather than standard lymphadenectomy, are expected to change clinical practice.


An extended lymphadenectomy – removal of additional lymph nodes beyond the extent of the standard procedure – in patients undergoing radical cystectomy (removal of bladder and nearby tissues) because of clinically localized muscle-invasive bladder cancer provides no patient benefit as measured by disease-free survival or overall survival times. It does, however, increase the risk of adverse events (side effects) and post-surgical death.

These primary results from the phase 3 SWOG S1011 clinical trial are being delivered in an oral presentation at the 2023 annual meeting of the American Society of Clinical Oncology in Chicago on June 5 (Abstract 4508).

The results will be presented by S1011 principal investigator Seth P. Lerner, MD, the Beth and Dave Swalm Chair in Urologic Oncology at Baylor College of Medicine and an investigator with the SWOG Cancer Research Network that led the study, a clinical trials group funded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).

The results of S1011 are expected to change clinical practice in treating these patients.

“Extended lymphadenectomy is considered a standard of care and is increasingly used,” Lerner said, “especially for patients with locally advanced bladder cancer, who have a higher risk of lymph node metastases.”

Once cancer invades the muscle of the bladder, it can also get into the blood and lymphatic system and can lodge in the lymph nodes. In about one-quarter of patients with muscle-invasive bladder cancer, the disease has already spread to regional lymph nodes.

For this reason, after removing the bladder in these patients, surgeons will also remove all of the lymph nodes in the primary landing zone from around the bladder. Removing those lymph nodes – known as a lymphadenectomy – significantly reduces the chances of the cancer returning within the pelvis.

The SWOG S1011 trial asked whether it was better to extend the lymphadenectomy to remove even more lymph nodes from a wider area, and whether this would reduce the risk of recurrent disease or death.

Surgeons participating in the trial had to first undergo a credentialing process designed specifically for the study. A total of 36 surgeons at 27 participating sites in the U.S. and Canada were credentialed, and they enrolled 658 patients, 618 of whom were eligible to be randomized.

These patients were randomized during their surgery, after the surgeon had determined the patient’s disease had not spread beyond the pelvis. All patients underwent a standard bilateral pelvic lymphadenectomy; those randomized to the investigative arm then also had an extended lymph node removal, with nodes removed at least up to the aortic bifurcation.

The median number of nodes removed was greater in the patients on the extended lymphadenectomy arm – 39 nodes vs 24 nodes on the control arm – but the percentage of nodes found to contain metastatic disease was similar on the two arms – 26 percent versus 24 percent, respectively.

Patients on the extended lymphadenectomy arm were more likely to experience grade 3 or 4 adverse events (serious side effects) within 90 days of surgery, regardless of attribution, than patients who received a standard lymphadenectomy – 49 percent of patients versus 42 percent. Additionally, the number of deaths within 90 days of surgery was also greater on the investigative arm – 19 patients versus 7 patients.

The SWOG S1011 team had hypothesized that the group of patients on the investigative arm would have improved disease-free and overall survival times compared to those on the control arm. However, no significant differences were seen between the extended versus standard lymphadenectomy arms in disease-free survival (HR = 1.10 [95% CI 0.87, 1.42], 2-sided p = 0.40) or in overall survival times (HR 1.15 [95% CI 0.89, 1.48] 2-sided p = 0.29).

Lerner noted that a definitive phase III surgical trial of this sort was an ideal fit for the NCI’s National Clinical Trials Network (NCTN).

“SWOG S1011 addressed an important surgical question, and the federally funded NCTN is uniquely suited for such practice-changing trials led by surgical oncologists,” Lerner said. “Collaboration across the NCTN was the key to success, as was equipoise from high-volume surgeons who recognized the lack of level I evidence supporting our current practice at the time we conceived the trial.”

Study S1011 is supported by the NCI, part of the NIH, led by SWOG, and conducted by the NIH-funded NCI NCTN. S1011 was funded by the NIH/NCI through grants U10CA180888, U10CA180819, U10CA180820, U10CA180821, and U10CA180863 and Canadian Cancer Society grant 707213. 

In addition to Lerner, co-authors on the S1011 abstract included Catherine Tangen, SWOG Statistics & Data Management Center and Fred Hutchinson Cancer Center; Robert S. Svatek, University of Texas Health San Antonio; Siamak Daneshmand, Oregon Health & Science University; Kamal Pohar, Ohio State University; Eila Skinner, Stanford University; Anne Schuckman, Oregon Health & Science University; Arthur I. Sagalowsky, UT Southwestern Medical Center; Norm D. Smith, University of Chicago; Ashish Kamat, MD Anderson Cancer Center; Wassim Kassouf, McGill University Health Center; Melissa Plets, SWOG Statistics & Data Management Center and Fred Hutchinson Cancer Center; Rick Bangs, Bladder Cancer Advocacy Network and SWOG Patient Advocates; Theresa M. Koppie, Oregon Health & Science University; Ajai Alva, University of Michigan; Francisco G. LaRosa, University of Colorado; Sumanta K. Pal, City of Hope Medical Center; Adam S. Kibel, Dana Farber Cancer Institute; Daniel J. Canter, Fox Chase Cancer Center (during trial) and Oschsner Medical Center (current); and Ian M. Thompson, Jr., CHRISTUS Santa Rosa Medical Center Hospital.

SWOG Cancer Research Network is part of the National Cancer Institute's National Clinical Trials Network and the NCI Community Oncology Research Program and is part of the oldest and largest publicly funded cancer research network in the nation. SWOG has more than 18,000 members in 45 states and nine foreign countries who design and conduct clinical trials to improve the lives of people with cancer. SWOG trials have led to the approval of 14 cancer drugs, changed more than 100 standards of cancer care, and saved more than 3 million years of human life. Learn more at, and follow us on Twitter at @SWOG.

Abstract Title: SWOG S1011: A phase III surgical trial to evaluate the benefit of a standard versus an extended lymphadenectomy performed at time of radical cystectomy for muscle invasive urothelial cancer.
Session Type/Title: Oral Abstract Session - Genitourinary Cancer—Kidney and Bladder
Session Date and Time: 6/5/2023, 11:30 AM-2:30 PM (Abstract 4508)



Study finds sex education tool improves reproductive health knowledge among adolescent girls

HUNTINGTON, W.Va. – A Marshall University study found that a virtual sex education tool improved reproductive health knowledge scores and measures of self-efficacy among adolescent girls. The findings, published last month in Sex Education, a leading international journal on sex, sexuality and relationships in education, found that sexual health knowledge scores on a validated scale increased among participants, along with improved measures of self-efficacy regarding birth control, healthy relationships and sexually transmitted infection (STI) prevention. Notably, ...

No-till revolution could stop Midwest topsoil loss in its tracks

American Geophysical Union 25 May 2023 AGU Release No. 22 For Immediate Release This press release and accompanying multimedia are available online at: No-till revolution could stop Midwest topsoil loss in its tracks If Midwestern farms all adopted low-intensity tilling practices or stopped tilling entirely, the erosion of critical topsoil could decrease by 95% in the next 100 years, new study finds AGU press contact: Rebecca ...

Computational method uncovers the effects of mutations in the noncoding genome

Less than two percent of the human genome codes for proteins, with the rest being noncoding and likely helping with gene regulation. Mutations in the noncoding genome often trigger trait changes that cause disease or disability by altering gene expression. However, it can be hard for scientists to track down which of numerous variants associated with a disease or other complex trait are the causal ones and to understand the mechanism of their effects. Researchers at the Brigham developed a new computational approach that hones in on small regions of the noncoding genome that genome-wide association studies (GWAS) identified ...

Extreme precipitation in northeast to increase 52% by the end of the century

Extreme precipitation in northeast to increase 52% by the end of the century
With a warmer climate creating more humid conditions in the Northeast, extreme precipitation events — defined as about 1.5 or more inches of heavy rainfall or melted snowfall in a day — are projected to increase in the Northeast by 52% by the end of the century, according to a new Dartmouth study. The findings are published in Climatic Change. "As climate change brings warmer temperatures, you have more water vapor in the atmosphere, which creates the right conditions for extreme precipitation," says first author Christopher J. Picard '23, an earth sciences major and undergraduate researcher in the Applied Hydroclimatology Group ...

Lung infection may be less transmissible than thought

A little-known bacterium — a distant cousin of the microbes that cause tuberculosis and leprosy — is emerging as a public health threat capable of causing severe lung infections among vulnerable populations, those with compromised immunity or reduced lung function. Recent research found that various strains of the bacterium, Mycobacterium abscessus, were genetically similar, stoking fears that it was spreading from person to person. But a new study by Harvard Medical School researchers published ...

Experimental decoy protects against SARS-CoV-2 infection

An experimental “decoy” provided long-term protection from infection by the pandemic virus in mice, a new study finds. Led by researchers at NYU Grossman School of Medicine, the work is based on how the virus that causes COVID-19, SARS-CoV-2, uses its spike protein to attach to a protein on the surface of the cells that line human lungs. Once attached to this cell surface protein, called angiotensin converting enzyme 2 (ACE2), the virus spike pulls the cell close, enabling the virus to enter the cell and hijack its machinery to make viral copies.  Earlier in the pandemic, pharmaceutical ...

Light conveyed by the signal transmitting molecule sucrose controls growth of plant roots

Plant growth is driven by light and supplied with energy through photosynthesis by green leaves. It is the same for roots that grow in the dark – they receive the products of photosynthesis, in particular sucrose, i.e. sugar, via the central transportation pathways of phloem. Dr. Stefan Kircher and Prof. Dr. Peter Schopfer from the University of Freiburg’s Faculty of Biology have now shown in experiments using the model plant Arabidopsis thaliana (thale cress) that the sucrose not only guarantees the supply of carbohydrates to the roots, it also acts as a signal transmitter for ...

Mitigating climate change through restoration of coastal ecosystems

One of the primary drivers of climate change is excess greenhouse gases like carbon dioxide in the atmosphere. Mitigating climate change in the coming century will require both decarbonization — electrifying the power grid or reducing fossil fuel-guzzling transportation —  and removing already existing carbon dioxide from the atmosphere, a process called carbon dioxide removal. Researchers at the Georgia Institute of Technology and Yale University are proposing a novel pathway through which coastal ecosystem restoration can permanently capture carbon dioxide from the atmosphere. Seagrass and mangroves — known as blue carbon ecosystems — naturally capture ...

Flexible nanoelectrodes can provide fine-grained brain stimulation

Flexible nanoelectrodes can provide fine-grained brain stimulation
HOUSTON – (May 30, 2023) – Conventional implantable medical devices designed for brain stimulation are often too rigid and bulky for what is one of the body’s softest and most delicate tissues. To address the problem, Rice University engineers have developed minimally invasive, ultraflexible nanoelectrodes that could serve as an implanted platform for administering long-term, high-resolution stimulation therapy. According to a study published in Cell Reports, the tiny implantable devices formed stable, long-lasting and seamless tissue-electrode ...

Teens with irregular sleep patterns have higher risk of school problems

DARIEN, IL – A new study to be presented at SLEEP 2023 found that teens with greater variability in their sleep patterns have a higher risk for school-related problems. Results show that the teens with greater night-to-night variability in the time they fell asleep were 42% more likely to have been suspended or expelled in the past two years, 29% more likely to have received a D or F in any course, and 26% more likely to have ever failed a course. The likelihood of suspension or expulsion was also 31% higher in teens with greater variability in sleep duration. “Variability in sleep duration and later sleep ...


Carnegie Mellon University launches WebAssembly Research Center

Racial discrimination among teens linked to unhealthy stress hormone levels

Psychological aspects of erectile dysfunction deserve more attention, health scientists say

Ochsner Health named to Newsweek’s America’s Greatest Workplaces for Parents and Families 2023

Your Zoom background might influence the first impression you make

Lack of financial planning linked to higher risk of death in US and UK

Male and female Olympic shooters perform equally well when targets are stationary, though men have the edge for moving targets, per analysis of 2021 Tokyo Olympics which trialed mixed-gender events

Tree rings reveal a new kind of earthquake threat to the Pacific Northwest

Researchers find potential way to tweak immune system to help it fight tuberculosis

Researchers discover disease-causing stem cells in lungs of cystic fibrosis patients

Combating distrust online: New GW study explains why current messaging efforts may not be effective

When needs compete, love trumps thirst

NIH awards merit grant for nanofiber research targeting metastatic lung tumors

UTA research: Wildlife loss five times slower in protected areas

Milestone for novel atomic clock

NSF backs Rice processor design, chip security research

St. Jude Children’s Research Hospital unveils the Domino’s Village

U of M Medical School professor receives $3.5 million to develop Tanzanian reproductive health curriculum for those with disabilities

How liver cells become scarring, and worse

Does form follow function? Johns Hopkins Medicine researchers advance understanding of why cell parts look the way they do

New study finds children of color and from low-income families are exposed to more toxic chemicals and experience greater harm

Community mobility and depressive symptoms during the pandemic

Cannabis use frequency and cannabis-related consequences in high-risk young adults across cannabis legalization

Decriminalizing drug possession not linked to higher overdose death rates in Oregon or Washington

Impact of genes linked to neurodevelopmental diseases found in Stanford Medicine-led study

Powering the quantum revolution: Quantum engines on the horizon

New proof for black hole spin

Monitoring of radio galaxy M87 confirms black hole spin

Desalination system could produce freshwater that is cheaper than tap water

Protecting lands slows biodiversity loss among vertebrates by five times

[] Extended lymph node removal does not benefit patients with clinically localized muscle-invasive bladder cancer
Results of the definitive SWOG S1011 phase 3 surgical trial, which also found increased toxicities for patients undergoing extended rather than standard lymphadenectomy, are expected to change clinical practice.